GGrantIndex
Sort

82,697 grants matching vaccine development

Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication

$1,887,460
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2025 · AI

NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines

$1,887,453
Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI

Lyme Disease: B cell epitope discovery and mechanisms of antibody protection

$1,887,202
Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2022 · AI

Mechanisms of naturally-acquired immunity to malaria

$1,887,168
Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Center for Integrative Research on Childhood Adversity

$1,887,090
Jennifer Hays-Grudo · Osu Center For Health Sciences · P20 · FY2023 · GM

Adjuvant Development Program

$1,886,967
Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2010 · AI

Engineered Listeria monocytogenes as an AIDS vaccine

$1,886,912
Immune Disease Institute, Inc. · P01 · FY2005 · AI

MASTER CONTRACT FOR PRECLINICAL DEVELOPMENT AIDS RESEARCH (BASIC)

$1,886,200
Phillip D Markham · Advanced Bioscience Laboratories, Inc. · N01 · FY2010 · AI

Host-tumor cell interaction in myeloma: therapeutic applications

$1,885,301
Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2014 · CA

Genetic and Biochemical Approaches to Tyrosine Kinase Function

$1,885,127
Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2012 · HG

Kaiser Washington Vaccine and Treatment Evaluation Unit

$1,884,389
Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2020 · AI

Immune Modulation/Hematopoietic Cell Transplantation

$1,883,752
Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2009 · AI

HIV VACCINE CLINICAL TRIALS UNIT

$1,883,671
Vanderbilt University · U01 · FY2005 · AI

Immunization and Immune Monitoring

$1,883,250
David C Montefiori · Duke University · U19 · FY2007 · AI

Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment

$1,882,718
E. John Wherry · University Of Pennsylvania · U19 · FY2011 · AI

Center for Research on Processes in Evolution

$1,882,717
Larry J Forney · University Of Idaho · P20 · FY2009 · RR

SPORE in Myeloid Malignancies

$1,881,692
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA

Live Vector Vaccines Against Agents of Bioterror

$1,881,608
University Of Maryland Baltimore · U19 · FY2004 · AI

SPORE in Prostate Cancer

$1,881,489
Samuel R Denmeade · Johns Hopkins University · P50 · FY2018 · CA

SPORE In Prostate Cancer

$1,881,400
Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2014 · CA

Interferon-inducing compounds for use as broad antivirals/adjuvants

$1,881,355
Peter Palese · Icahn School Of Medicine At Mount Sinai · N01 · FY2013 · AI

Project 3- Mucosal Determinants of Virus Transmission

$1,881,335
Guido Silvestri · University Of Maryland Baltimore · P01 · FY2018 · AI

T CELL MEMORY TO PATHOGENS: GENERATION AND FUNCTION

$1,880,982
Susan L Swain · Trudeau Institute, Inc. · P01 · FY2007 · AI

T CELL MEMORY TO PATHOGENS: GENERATION AND FUNCTION

$1,880,848
Susan L Swain · Trudeau Institute, Inc. · P01 · FY2006 · AI

Engineered Listeria monocytogenes as an AIDS vaccine

$1,880,724
Judy Lieberman · Immune Disease Institute, Inc. · P01 · FY2007 · AI